Overview
DR LAL PATHLABS
?
Shankha Banerjee
See more contacts
Medical and Diagnostic Laboratories
,
Offices of Physicians
,
Scientific Research and Development Services
,
Pathological laboratory
,
Pathologist
See All Industries , Offices and clinics of medical doctors, nec , Medical centers Medical research
See Fewer Industries
See All Industries , Offices and clinics of medical doctors, nec , Medical centers Medical research
See Fewer Industries
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
Actual
$296.92 million
Actual
10.55%
36.18%
$27,168
MAR
?
?
NSE Ind:LALPATHLAB
Contacts
Get in Touch with 14 Principals* and 154 Contacts
-
Shankha BanerjeeChief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2024 (12 month period) in USD
Annual Revenue 2025
$296.92 million
USD
Actual
1 USD = 82.8981 INR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Operating Cash | $69 | $65 | $55 |
| Net Investing Cash | -$37 | -$3 | -$35 |
| Net Financing Cash | -$40 | -$50 | -$34 |
| Net Change in Cash | -$8 | $12 | -$14 |
| Cash at Beginning of Period | $44 | $32 | $46 |
| Cash at End of Period | $35 | $44 | $32 |
| Capital Expenditure | -$7 | -$7 | -$5 |
| Assets (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $35 | $44 | $32 |
| Accounts Receivable | $11 | $9 | $9 |
| Inventories | $4 | $5 | $4 |
| Other Current Assets | $114 | $79 | $73 |
| Asset Summary | |||
| Total Current Assets | $164 | $136 | $117 |
| Tangible Fixed Assets | $41 | $42 | $49 |
| Intangible Assets | $30 | $37 | $43 |
| Total Assets | $27,168 | $24,560 | $23,856 |
| Liabilities (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $24 | $23 | $19 |
| Short-Term Debt | $ | $10 | $18 |
| Other Current Liabilities | $25 | $24 | $19 |
| Liability Summary | |||
| Total Current Liabilities | $49 | $56 | $57 |
| Long-Term Debt | $ | $ | $10 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $62 | $69 | $83 |
| Stakeholder's Equity (mil) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Equity | |||
| Common Stock | $10 | $10 | $10 |
| Retained Earnings | $ | $182 | $163 |
| Equity Summary | |||
| Total Equity | $262 | $223 | $201 |
| Shares Outstanding | 83,367,273 | 83,213,077 | 82,940,578 |